BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5999012)

  • 1. [Depot drugs in the treatment of resistant forms of pulmonary tuberculosis. The experience of the Conjunto Sanatorial Octávio de Freitas (Recife)].
    Rizzo A; Moura N; Magalhães M; Antunes G; Campelo C
    Rev Bras Med; 1966 Dec; 23(12):850-2. PubMed ID: 5999012
    [No Abstract]   [Full Text] [Related]  

  • 2. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
    Rizzo A; Magalhães M; Moura N
    Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of kanamycin in a triple regimen of kanamycin, cycloserine and ethionamide in the treatment of far-advanced cases of pulmonary tuberculosis with tubercle bacilli resistant to primary drugs.
    Oka S; Motomiya M; Kato S; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Apr; 14(1):91-3. PubMed ID: 4968094
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 5. Duration of application and change of a regimen with secondary drugs.
    Oka S; Takase Y; Kato S
    Sci Rep Res Inst Tohoku Univ Med; 1968 Oct; 15(1):46-9. PubMed ID: 4308926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
    Bethlem N; Mendes W
    Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of two regimens, KM-TH-CS and KM-TH-EB, in retreatment cases of pulmonary tuberculosis].
    Aoyagi T; Fukuhara Y; Hondo G; Matsumiya T; Murata A
    Kekkaku; 1970 Jan; 45(1):27-36. PubMed ID: 5416951
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR
    Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical applications of ethambutol.
    Pyle MM
    Tubercle; 1969 Mar; 50():Suppl:30-2. PubMed ID: 4918611
    [No Abstract]   [Full Text] [Related]  

  • 10. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M; Tarantino AB; Mac Dowell A; Costa JA; Cunha JM; Pantoja W
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract]   [Full Text] [Related]  

  • 11. [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis].
    Ivanova ES
    Antibiotiki; 1967 Aug; 12(8):727-32. PubMed ID: 4968419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Administration of reserve antitubercular drugs in a single daily dose].
    Bek E; Bukalska Z; Zachara A
    Gruzlica; 1968; 37(1):43-7. PubMed ID: 5720037
    [No Abstract]   [Full Text] [Related]  

  • 13. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 14. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The course and results of treatment of pulmonary tuberculosis as a function of the dosage of Pyrazinamide].
    Malinowska B; Pawlak F
    Gruzlica; 1970; 38(6):531-5. PubMed ID: 4317029
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
    Tsukamura M
    Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pyrazinamide, cycloserine and ethionamide in the complex treatment of pulmonary tuberculosis].
    Aspevik E
    Tidsskr Nor Laegeforen; 1967 Mar; 87(6):548-54. PubMed ID: 6047184
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison among single, double and triple drug regimens in retreatment. (the seventh series of the trial, B)].
    Kekkaku; 1968 Jun; 43(6):199-207. PubMed ID: 5701828
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of ethionamide aerosols in the treatment of pulmonary tuberculosis].
    Kulik NM
    Probl Tuberk; 1971; 49(4):68-9. PubMed ID: 5138430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.